Whole-breast irradiation after conservative surgery is the standard treatment for early breast cancer. The purpose of this study is to report the late toxicity, cosmetic result, and disease control in a group of patients treated with hypofractionated radiotherapy (RT) comparing results with retrospective data of a control group who underwent conventional RT.
From 2006 to 2008, 85 patients were treated with hypofractionated schedule to dose of 45 Gy, 2.25 Gy/fr, followed by a boost. We evaluated late toxicity, cosmetic result, and disease control. The data were compared to a control group of 70 patients who underwent conventional RT before 2006.
At 8 years of follow-up, the cumulative incidence of late skin toxicity was 6.2 in the hypofractionated RT group and 7.5 in the standard RT group (p = 0.94). The cumulative incidence of late subcutaneous tissue toxicity was 11.6 in the hypofractionated RT group and 18.7 in the standard RT group (p = 0.23). Cosmetic outcome was rated as excellent or good in 84/85 patients of the hypofractionated RT group and in 68/70 patients of the conventional RT group (p = 0.7). No statistically significant differences were found in terms of local control (p = 0.05), disease-free survival (p = 0.06), or overall survival (p = 0.17) between the 2 groups.
The present analysis, focused on long-term effects, disease control, and survival, confirms, in a daily practice setting, the low incidence of skin atrophy and fibrosis, the satisfactory cosmetic outcome, and the high grade of local and distant disease control with hypofractionated schedule.
Tumori 2016; 102(4): 398 - 403
Article Type: ORIGINAL RESEARCH ARTICLE
AuthorsLetizia Deantonio, Salvatore Cozzi, Sara Tunesi, Marco Brambilla, Laura Masini, Carla Pisani, Giuseppina Gambaro, Corrado Magnani, Marco Krengli
- • Accepted on 22/02/2016
- • Available online on 26/05/2016
- • Published in print on 03/08/2016
This article is available as full text PDF.
- Deantonio, Letizia [PubMed] [Google Scholar] 1, 2
- Cozzi, Salvatore [PubMed] [Google Scholar] 1
- Tunesi, Sara [PubMed] [Google Scholar] 2, 3
- Brambilla, Marco [PubMed] [Google Scholar] 4
- Masini, Laura [PubMed] [Google Scholar] 1
- Pisani, Carla [PubMed] [Google Scholar] 1
- Gambaro, Giuseppina [PubMed] [Google Scholar] 1
- Magnani, Corrado [PubMed] [Google Scholar] 2, 3
- Krengli, Marco [PubMed] [Google Scholar] 1, 2, * Corresponding Author (email@example.com)
Radiotherapy, University Hospital “Maggiore della Carità,” Novara - Italy
Department of Translational Medicine, University of “Piemonte Orientale,” Novara - Italy
Biostatistics and Clinical Epidemiology, University of “Piemonte Orientale,” Novara - Italy
Medical Physics, University Hospital “Maggiore della Carità,” Novara - Italy